Drug resistance and apoptosis in ENU-induced rat brain tumors treated with anti-cancer drugs

Journal of Neuro-Oncology

Volumn 36, Issue 2, 1998, Pages 105-112

  Yabuno, Toru ^a   Konishi, Noboru ^a   Nakamura, Mitsutoshi ^a   Tsuzuki, Toshihide ^a   Tsunoda, Shigeru ^b   Sakaki, Toshisuke ^a   Hiasa, Yoshio ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Brain tumor; Drug resistance; ENU; GST; p glycoprotein; Rat

Indexed keywords

ANTINEOPLASTIC AGENT; DNA NUCLEOTIDYLEXOTRANSFERASE; ETHYLNITROSOUREA; GLUTATHIONE TRANSFERASE; GLYCOPHORIN A; GLYCOPROTEIN; GLYCOPROTEIN P; NIMUSTINE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER INCIDENCE; CONTROLLED STUDY; DNA NICK TRANSLATION; DRUG RESISTANCE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRENATAL EXPOSURE; PROTEIN EXPRESSION; RAT; TUMOR VOLUME;

EID: 0031950742     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005878402133     Document Type: Article

References (38)

1. Feun LG, Savaraj N, Landy HJ: Drug resistance in brain tumors. J Neuro-Oncol 20: 165-196, 1994
2. Juliano RL, Ling VA: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455: 152-162, 1976
3. Kiwit JCW, Hertel A, Matuschek AE: Reversal of chemoresistance in malignant gliomas by calcium antagonists: correlation with the expression of multidrug-resistant p-glycoprotein. J Neurosurg 81: 587-594, 1994
4. Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH: Expression of anionic glutathione-S-transferase and p-glycoprotein genes in human tissues and tumors. Cancer Res 49: 1422-1428, 1989
5. Cordon-Cordo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino J: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695-698, 1989
6. Grant R, Ironside JW: Glutathione S-transferases and cytochrome p450 detoxifying enzyme distribution in human cerebral glioma. J Neuro-Oncol 25: 1-7, 1995
7. Hara A, Niikawa S, Zhang W, Sakai N, Yamada H, Yoshimi N, Mori H: Identification of placental form of glutathione S-transferase in ACNU-resistant murine glioma cell lines. J Neuro-Oncol 17: 205-213, 1993
8. Smith MT, Evans CG, Doane-Setzer P, Castro VM, Tahir MK, Mannervik B: Denitrosation of 1,3-bis(2-cloroethyl)-1-nitrosourea by class mu glutathione transferase and its role in cellular resistance in rat brain tumor cells. Cancer Res 49: 2621-2625, 1989
9. Black SM, Wolf CR: The role of glutathione-dependent enzymes in drug resistance. Pharma Ther 51: 139-154, 1991
10. Kitahara A, Satoh K, Sato K: Properties of the increased glutathione S-transferase A form in rat preneoplastic hepatic lesions induced by chemical carcinogens. Biochem Biophys Comm 112: 20-28, 1988
11. Mannervik B, Jensson H: Binary combinations of four protein subunits with different catalytic specificities explain the relationship between six basic glutathione S-transferases in rat liver cytosol. J Biol Chem 257: 9909-9912, 1982
12. 6-methylguanine in ACNU-resistant brain tumors. J Neuro-Oncol 19: 51-59, 1994
13. Ling Y-H, Priebe W, Perez-Soler R: Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53: 1845-1852, 1993
14. Evans DL, Dive C: Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133-2139, 1993
15. Eastman A: Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280, 1990
16. Carson DA, Ribeiro JA: Apoptosis and disease. Lancet 341: 1251-1254, 1993
17. Gavrieli Y, Sherman Y, Ban-Sasson SA: Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
18. Jones EL, Searle CE, Smith WT: Tumours of the nervous system induced in rats by the neonatal administration of N-ethyl-nitrosourea. J Pathol 109: 123-139, 1973
19. Druckrey H, Ivankovic S, Preussmann R: Teratogenic and carcinogenic effects in the offspring after a single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378-1379, 1966
20. Grossi-Paoletti E, Paoletti P, Pezzotta S, Schiffer D, Fabiani A: Tumors of the nervous system induced by ethylnitrosourea administered either intracerebrally or subcutaneously to newborn rats. Morphological and biochemical characteristics. J Neurosurg 37: 580-590, 1972
21. Ali-Osman F, Stein DE, Renwick A: Glutathione content and glutathione S-transferase expression in 1,3-bis(2-cloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res 50: 6976-6980, 1990
22. Gunji H, Kharbanda S, Kufe D: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-b-D-arabinofuranosylcytosine. Cancer Res 51: 741-743, 1991
23. Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E: Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 55: 2122-2128, 1995
24. Collins RJ, Harmon BV, Souvlis T, Pope JH, Kerr JFR: Effects of cycloheximide on B-chronic lymphocytic leukaemia and normal lymphocytes in vitro: induction of apoptosis. Br J Cancer 64: 518-522, 1991
25. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence upon macromolecular synthesis. J Pathol 142: 62-67, 1984
26. Hartwell LH, Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634, 1989
27. Lotem J, Sachs L: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Differ 4: 41-47, 1993
28. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
29. Fisher D: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994
30. Reed JC: Bcl-2 and regulation of programmed cell death. J Cell Biol 124: 1-6, 1994
31. Kokunai T, Sawa T, Tamaki N: Localization of apoptotic cells in situ of brain tumors. Brain Tumor Pathol 12: 15-21, 1995
32. Schiffer D: On the occurrence of oligodendroglioma-like areas in neurinomas experimentally induced in the rat by nitrosourea derivatives. J Neurol Sci 19: 45-52, 1973
33. Vaquero J, Oya S, Coca S, Zurita M: Experimental induction of primitive neuro-ectodermal tumours in rats: a reappraisement of the ENU-model of neurocarcinogenesis. Acta Neurochir 131: 294-301, 1994
34. Ikeda T, Mashimoto H, Iwasaki K, Shimokawa I, Matsuo T: A sequential ultrastructural and histoautoradiographic study of early neoplastic lesions in ethylnitrosourea-induced rat glioma. Acta Pathol Jpn 39: 487-495, 1989
35. Cabral FR, Brady RC, Schlber MJ: A mechanism of cellular resistance to drugs that interfere with microtubule assembly. Ann NY Acad Sci 46: 748-756, 1986
36. Lee WC, Lin KY, Chen KN, Lai YK: Induction of HSP70 is associated with vincristine resistance in heat-shocked 9L rat brain tumor cells. Br J Cancer 66: 653-659, 1992
37. Nakamura M, Tsunoda S, Sakaki T, Konishi N, Hiasa Y: Immunohistochemical and biochemical studies on the expression of glutathione S-transferase-π in human brain tumors. Brain Tumor Pathol 9: 49-54, 1992
38. Ali-Osman: Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstand cross-linking by glutathione. Cancer Res 49: 5258-5261, 1989